<p>Cross Country Healthcare（納斯達克股票代碼：CCRN - 獲取免費報告）於週四發佈了其財報。該商業服務提供商報告本季度每股收益為（$0.03），超出分析師一致預期的（$0.05）$0.02，FiscalAI 報道。該公司本季度的收入為 2.4106 億美元，而分析師預期為 2.3684 億美元。Cross Country Healthcare 的淨利潤率為-9.84%，股本回報率為-0.71%。</p>
<h2>Cross Country Healthcare 股票表現</h2>
<ul>
<li>在降息前值得購買的前兩隻小型醫療股</li>
</ul>
<p>週五午盤交易中，CCRN 上漲$0.09，達到$13.18。該公司的交易量為 1,809,683 股，而其平均交易量為 620,874 股。該公司的市值為 4.244 億美金，市盈率為-4.32，市盈增長比率為 13.78，貝塔值為 0.35。Cross Country Healthcare 的 12 個月最低價為$7.43，最高價為$14.99。該公司的 50 日簡單移動平均線為$9.69，200 日簡單移動平均線為$9.66。</p>
<h2>更多 Cross Country Healthcare 新聞</h2>
<p>以下是本週影響 Cross Country Healthcare 的主要新聞：</p>
<ul>
<li>積極情緒：Cross Country Healthcare 同意被 Knox Lane 以全現金交易收購，給股東提供每股固定收購價$13.25，支持了該股票。Cross Country Healthcare 將被 Knox Lane 以價值 4.37 億美元的全現金交易收購</li>
<li>積極情緒：該公司第一季度的業績超出華爾街預期，損失小於預期的每股$0.03，收入為 2.4106 億美元，這可能為情緒提供了一些支持。Cross Country Healthcare（CCRN）報告第一季度虧損，超出收入預期</li>
<li>中性情緒：Benchmark 重申對 CCRN 的 <strong>持有</strong> 評級，而 Wedbush 將該股票下調至 <strong>持有</strong> 並將其目標價下調至$13.25，反映出相對於交易價格的有限上行空間。Benchmark 重申持有評級</li>
<li>中性情緒：一些評論認為投資者可能希望在合併公告後兑現，但這主要是對收購消息的反應，而不是單獨的運營發展。Cross Country Healthcare：在新合併後是時候兑現了</li>
</ul>
<h2>對 Cross Country Healthcare 的對沖基金看法</h2>
<ul>
<li>這家小型醫療公司表現優於其指數</li>
</ul>
<p>幾家大型投資者最近對該公司的持倉進行了調整。Alliancebernstein L.P.在第二季度將其在 Cross Country Healthcare 的股份增加了 4.0%。Alliancebernstein L.P.現在擁有 2,438,282 股該商業服務提供商的股票，價值 3182 萬美元，此前在該期間內增持了 94,798 股。高盛集團在第一季度將其在 Cross Country Healthcare 的股份增加了 56.9%。高盛集團現在擁有 1,095,178 股該商業服務提供商的股票，價值 1630.7 萬美元，此前在該期間內增持了 397,216 股。Quinn Opportunity Partners LLC 在第四季度獲得了 Cross Country Healthcare 的新頭寸，價值 847 萬美元。查爾斯·施瓦布投資管理公司在第四季度將其在 Cross Country Healthcare 的股份增加了 28.0%。查爾斯·施瓦布投資管理公司現在擁有 969,458 股該商業服務提供商的股票，價值 785.3 萬美元，此前在該期間內增持了 211,925 股。最後，Geode Capital Management LLC 在第四季度將其在 Cross Country Healthcare 的股份增加了 1.7%。Geode Capital Management LLC 現在擁有 893,620 股該商業服務提供商的股票，價值 724 萬美元，此前在該期間內增持了 14,733 股。機構投資者和對沖基金持有該公司 96.03% 的股份。</p>
<h2>分析師升級和降級</h2>
<p>幾位股票研究分析師最近對該股票發佈了報告。Wedbush 將 Cross Country Healthcare 的股票評級從 “跑贏大盤” 下調至 “持有”，並在週四的研究報告中將其目標價從$15.00 下調至$13.25。Cross Research 在 3 月 5 日的研究報告中對 Cross Country Healthcare 設定了$14.00 的目標價。花旗集團在週四的報告中將 Cross Country Healthcare 的評級從 “市場跑贏” 下調至 “市場表現”。Benchmark 在週五的報告中重新發布了對 Cross Country Healthcare 的 “持有” 評級。最後，Weiss Ratings 在 3 月 27 日的報告中重新發布了對 Cross Country Healthcare 的 “賣出（e+）” 評級。一位研究分析師對該股票給予了買入評級，七位分析師給予了持有評級，一位分析師給予了賣出評級。根據 MarketBeat，該公司目前的平均評級為 “持有”，共識目標價為$12.31。</p>
<p><strong>查看我們關於 Cross Country Healthcare 的最新研究報告</strong></p>
<h2>Cross Country Healthcare 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Cross Country Healthcare, Inc.總部位於佛羅里達州博卡拉頓，是美國領先的醫療勞動力解決方案提供商。該公司專注於護理和相關健康專業人員的招聘、安置和管理，包括旅行和永久性職位。通過其綜合平台，Cross Country Healthcare 為醫院、健康系統和長期護理設施提供服務，通過匹配合格的臨牀人才與不同護理環境中的患者護理需求。</p>
<p>公司的核心服務包括旅行護士和相關健康人員的招聘、臨時人員招聘、永久安置服務和管理服務項目。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Cross Country Healthcare</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Cross Country Healthcare 嗎？</h2>
<p>在考慮 Cross Country Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Cross Country Healthcare 並不在名單上。</p>
<p>雖然 Cross Country Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Cross Country醫療保健

美國醫療保健供應商 ETF - iShares

醫療業 ETF - SPDR

標普全球醫療股指數 ETF - iShares

標普醫療保健服務 ETF - SPDR

醫療業 ETF - Vanguard

<p>Cross Country Healthcare（納斯達克代碼：CCRN）報告的季度每股收益為（$0.03），超出預期的（$0.05）$0.02。該公司實現收入 2.4106 億美元，超過預期的 2.3684 億美元。儘管淨利潤率為負的 9.84% 和股本回報率為-0.71%，但股價略微上漲至$13.18。該公司將被 Knox Lane 以每股$13.25 收購，這影響了市場情緒。分析師的評級不一，有些下調了該股票的評級，而其他則維持持有評級</p>

<p>Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) released its earnings results on Thursday. The business services provider reported ($0.03) earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02, FiscalAI reports. The firm had revenue of $241.06 million during the quarter, compared to analyst estimates of $236.84 million. Cross Country Healthcare had a negative net margin of 9.84% and a negative return on equity of 0.71%.</p>
<div class="lb-trans"><p>Cross Country Healthcare（納斯達克股票代碼：CCRN - 獲取免費報告）於週四發佈了其財報。該商業服務提供商報告本季度每股收益為（$0.03），超出分析師一致預期的（$0.05）$0.02，FiscalAI 報道。該公司本季度的收入為 2.4106 億美元，而分析師預期為 2.3684 億美元。Cross Country Healthcare 的淨利潤率為-9.84%，股本回報率為-0.71%。</p>
</div><h2>Cross Country Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 股票表現</h2>
</div><ul>
<li>Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts</li>
</ul>
<div class="lb-trans"><ul>
<li>在降息前值得購買的前兩隻小型醫療股</li>
</ul>
</div><p>CCRN traded up $0.09 during midday trading on Friday, hitting $13.18. The company had a trading volume of 1,809,683 shares, compared to its average volume of 620,874. The company has a market capitalization of $424.40 million, a PE ratio of -4.32, a P/E/G ratio of 13.78 and a beta of 0.35. Cross Country Healthcare has a twelve month low of $7.43 and a twelve month high of $14.99. The firm's 50-day simple moving average is $9.69 and its 200-day simple moving average is $9.66.</p>
<div class="lb-trans"><p>週五午盤交易中，CCRN 上漲$0.09，達到$13.18。該公司的交易量為 1,809,683 股，而其平均交易量為 620,874 股。該公司的市值為 4.244 億美金，市盈率為-4.32，市盈增長比率為 13.78，貝塔值為 0.35。Cross Country Healthcare 的 12 個月最低價為$7.43，最高價為$14.99。該公司的 50 日簡單移動平均線為$9.69，200 日簡單移動平均線為$9.66。</p>
</div><h2>More Cross Country Healthcare News</h2>
<div class="lb-trans"><h2>更多 Cross Country Healthcare 新聞</h2>
</div><p>Here are the key news stories impacting Cross Country Healthcare this week:</p>
<div class="lb-trans"><p>以下是本週影響 Cross Country Healthcare 的主要新聞：</p>
</div><ul>
<li>Positive Sentiment: Cross Country Healthcare agreed to be acquired by Knox Lane in an all-cash transaction, giving shareholders a fixed buyout price of $13.25 per share and supporting the stock. Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million</li>
<li>Positive Sentiment: The company’s Q1 results beat Wall Street expectations, with a smaller-than-expected loss of $0.03 per share and revenue of $241.06 million, which may have added some support to sentiment. Cross Country Healthcare (CCRN) Reports Q1 Loss, Beats Revenue Estimates</li>
<li>Neutral Sentiment: Benchmark reaffirmed its <strong>hold</strong> rating on CCRN, while Wedbush downgraded the stock to <strong>hold</strong> and trimmed its price target to $13.25, reflecting limited upside versus the deal price. Benchmark Reaffirms Hold Rating</li>
<li>Neutral Sentiment: Some commentary suggested investors may want to cash out after the merger announcement, but this is largely a reaction to the acquisition news rather than a separate operating development. Cross Country Healthcare: Time To Cash Out After A New Merger</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：Cross Country Healthcare 同意被 Knox Lane 以全現金交易收購，給股東提供每股固定收購價$13.25，支持了該股票。Cross Country Healthcare 將被 Knox Lane 以價值 4.37 億美元的全現金交易收購</li>
<li>積極情緒：該公司第一季度的業績超出華爾街預期，損失小於預期的每股$0.03，收入為 2.4106 億美元，這可能為情緒提供了一些支持。Cross Country Healthcare（CCRN）報告第一季度虧損，超出收入預期</li>
<li>中性情緒：Benchmark 重申對 CCRN 的 <strong>持有</strong> 評級，而 Wedbush 將該股票下調至 <strong>持有</strong> 並將其目標價下調至$13.25，反映出相對於交易價格的有限上行空間。Benchmark 重申持有評級</li>
<li>中性情緒：一些評論認為投資者可能希望在合併公告後兑現，但這主要是對收購消息的反應，而不是單獨的運營發展。Cross Country Healthcare：在新合併後是時候兑現了</li>
</ul>
</div><h2>Hedge Funds Weigh In On Cross Country Healthcare</h2>
<div class="lb-trans"><h2>對 Cross Country Healthcare 的對沖基金看法</h2>
</div><ul>
<li>This Small-Cap Healthcare Name Is Outperforming Its Index</li>
</ul>
<div class="lb-trans"><ul>
<li>這家小型醫療公司表現優於其指數</li>
</ul>
</div><p>Several large investors have recently made changes to their positions in the company. Alliancebernstein L.P. lifted its stake in shares of Cross Country Healthcare by 4.0% during the second quarter. Alliancebernstein L.P. now owns 2,438,282 shares of the business services provider's stock valued at $31,820,000 after acquiring an additional 94,798 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Cross Country Healthcare by 56.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,095,178 shares of the business services provider's stock valued at $16,307,000 after acquiring an additional 397,216 shares during the period. Quinn Opportunity Partners LLC acquired a new position in shares of Cross Country Healthcare during the fourth quarter valued at $8,470,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Cross Country Healthcare by 28.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 969,458 shares of the business services provider's stock valued at $7,853,000 after acquiring an additional 211,925 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of Cross Country Healthcare by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 893,620 shares of the business services provider's stock valued at $7,240,000 after acquiring an additional 14,733 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.</p>
<div class="lb-trans"><p>幾家大型投資者最近對該公司的持倉進行了調整。Alliancebernstein L.P.在第二季度將其在 Cross Country Healthcare 的股份增加了 4.0%。Alliancebernstein L.P.現在擁有 2,438,282 股該商業服務提供商的股票，價值 3182 萬美元，此前在該期間內增持了 94,798 股。高盛集團在第一季度將其在 Cross Country Healthcare 的股份增加了 56.9%。高盛集團現在擁有 1,095,178 股該商業服務提供商的股票，價值 1630.7 萬美元，此前在該期間內增持了 397,216 股。Quinn Opportunity Partners LLC 在第四季度獲得了 Cross Country Healthcare 的新頭寸，價值 847 萬美元。查爾斯·施瓦布投資管理公司在第四季度將其在 Cross Country Healthcare 的股份增加了 28.0%。查爾斯·施瓦布投資管理公司現在擁有 969,458 股該商業服務提供商的股票，價值 785.3 萬美元，此前在該期間內增持了 211,925 股。最後，Geode Capital Management LLC 在第四季度將其在 Cross Country Healthcare 的股份增加了 1.7%。Geode Capital Management LLC 現在擁有 893,620 股該商業服務提供商的股票，價值 724 萬美元，此前在該期間內增持了 14,733 股。機構投資者和對沖基金持有該公司 96.03% 的股份。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>Several equities research analysts have recently issued reports on the stock. Wedbush downgraded shares of Cross Country Healthcare from an &#34;outperform&#34; rating to a &#34;hold&#34; rating and lowered their price objective for the stock from $15.00 to $13.25 in a research note on Thursday. Cross Research set a $14.00 price objective on Cross Country Healthcare in a research note on Thursday, March 5th. Citigroup downgraded Cross Country Healthcare from a &#34;market outperform&#34; rating to a &#34;market perform&#34; rating in a report on Thursday. Benchmark reissued a &#34;hold&#34; rating on shares of Cross Country Healthcare in a report on Friday. Finally, Weiss Ratings reissued a &#34;sell (e+)&#34; rating on shares of Cross Country Healthcare in a report on Friday, March 27th. One research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of &#34;Hold&#34; and a consensus target price of $12.31.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對該股票發佈了報告。Wedbush 將 Cross Country Healthcare 的股票評級從 “跑贏大盤” 下調至 “持有”，並在週四的研究報告中將其目標價從$15.00 下調至$13.25。Cross Research 在 3 月 5 日的研究報告中對 Cross Country Healthcare 設定了$14.00 的目標價。花旗集團在週四的報告中將 Cross Country Healthcare 的評級從 “市場跑贏” 下調至 “市場表現”。Benchmark 在週五的報告中重新發布了對 Cross Country Healthcare 的 “持有” 評級。最後，Weiss Ratings 在 3 月 27 日的報告中重新發布了對 Cross Country Healthcare 的 “賣出（e+）” 評級。一位研究分析師對該股票給予了買入評級，七位分析師給予了持有評級，一位分析師給予了賣出評級。根據 MarketBeat，該公司目前的平均評級為 “持有”，共識目標價為$12.31。</p>
</div><p><strong>View Our Latest Research Report on Cross Country Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Cross Country Healthcare 的最新研究報告</strong></p>
</div><h2>Cross Country Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.</p>
<div class="lb-trans"><p>Cross Country Healthcare, Inc.總部位於佛羅里達州博卡拉頓，是美國領先的醫療勞動力解決方案提供商。該公司專注於護理和相關健康專業人員的招聘、安置和管理，包括旅行和永久性職位。通過其綜合平台，Cross Country Healthcare 為醫院、健康系統和長期護理設施提供服務，通過匹配合格的臨牀人才與不同護理環境中的患者護理需求。</p>
</div><p>The company's core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.</p>
<div class="lb-trans"><p>公司的核心服務包括旅行護士和相關健康人員的招聘、臨時人員招聘、永久安置服務和管理服務項目。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Cross Country Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Cross Country Healthcare</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=CCRN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cross Country Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Cross Country Healthcare 嗎？</h2>
</div><p>Before you consider Cross Country Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cross Country Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Cross Country Healthcare 並不在名單上。</p>
</div><p>While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cross Country Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Cross Country Healthcare (NASDAQ:CCRN) Releases Earnings Results, Beats Expectations By $0.02 EPS

Market Beat

AllianceBernstein

高盛

嘉信理財

Dan IVES Wedbush AI Revolution ETF

花旗

GS Hldg R

SCHWAB(CHARLES)CORP 5.95% DEP SHS REP 1/40 NON CUM PERP PF D

SCHWAB(CHARLES)CORP 4.450% DEP SHS REP 1/40TH N-CUM PFD SERJ

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Cross Country Healthcare（納斯達克代碼：CCRN）公佈財報，超出預期每股收益 0.02 美元